Your browser doesn't support javascript.
loading
Relationship of T- and B-cell kinetics to clinical response in patients with relapsed/refractory non-Hodgkin lymphoma treated with blinatumomab.
Nägele, Virginie; Zugmaier, Gerhard; Goebeler, Maria-Elisabeth; Viardot, Andreas; Bargou, Ralf; Kufer, Peter; Klinger, Matthias.
Afiliação
  • Nägele V; Amgen Research (Munich) GmbH, Munich, Germany. Electronic address: vnaegele@amgen.com.
  • Zugmaier G; Amgen Research (Munich) GmbH, Munich, Germany.
  • Goebeler ME; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.
  • Viardot A; Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany.
  • Bargou R; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.
  • Kufer P; Amgen Research (Munich) GmbH, Munich, Germany.
  • Klinger M; Amgen Research (Munich) GmbH, Munich, Germany.
Exp Hematol ; 100: 32-36, 2021 08.
Article em En | MEDLINE | ID: mdl-34228983

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfócitos B / Linfócitos T / Anticorpos Biespecíficos / Antineoplásicos Imunológicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfócitos B / Linfócitos T / Anticorpos Biespecíficos / Antineoplásicos Imunológicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article